Monday, January 25, 2021

The latest to your inbox twice a week.

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine

0

Discrepancies in how countries define and evaluate difficult-to-diagnose HPV vaccine complications may affect their conclusions about the vaccine’s safety. Japan and Colombia suspended their HPV vaccine recommendations after encountering a significant number of cases of complications; the fact that some cases were “rare” or “clinically undefined” did not sway their decision. There is a need for unbiased monitoring and reporting of adverse reactions to HPV vaccination “to ensure that the benefits of vaccines outweigh the risks of adverse reactions.

Research Paper Url - https://childrenshealthdefense.org/wp-content/uploads/Cervantes-2018-Discrepancies-in-the-evaluation-of-the-safety-of-the-human-papillomavirus-vaccine.pdf